Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Recombinant HIV (human immunodeficiency virus) defective virus and preparation method thereof

A technology of defective viruses and viruses, applied in the field of clinical medicine, can solve the problems of no cure for HIV virus infection clinical treatment methods, no complete cure of HIV virus infection scientific research, easy to produce immune response and other problems, long time to achieve effect, low treatment cost Effect

Pending Publication Date: 2020-06-30
北京君禾药业有限公司
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Moreover, the carriers used are all disposable, requiring multiple injections for treatment, which is prone to immune reactions, and it is impossible to cure HIV infection in this direction
[0012] To sum up, there is currently no scientific research on the complete cure of HIV virus infection in the world, let alone a clinical treatment method to cure HIV virus infection

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Recombinant HIV (human immunodeficiency virus) defective virus and preparation method thereof
  • Recombinant HIV (human immunodeficiency virus) defective virus and preparation method thereof
  • Recombinant HIV (human immunodeficiency virus) defective virus and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0050] Reference will now be made in detail to various embodiments, one or more examples of which are illustrated in the figures. Each example is provided by way of explanation, not meant as a limitation. For example, features illustrated or described as part of one embodiment can be used or combined with any other embodiment to yield a still further embodiment. The present invention is intended to cover such modifications and variations.

[0051]The present invention adopts the RNAi technology of intracellular immunity, uses the recombinant HIV deficient virus as a carrier, and transports the miRNA that kills the env region and env mRNA in the HIV genome to various cells that may be infected by HIV in the human body. Completely kill the HIV virus to achieve the purpose of curing HIV virus infection.

[0052] The preparation method of the whole gene sequence infectious clone and plasmid proposed by the present invention comprises the following steps: using the virus strain o...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a recombinant HIV (human immunodeficiency virus) defective virus and a preparation method thereof. According to the recombinant HIV defective virus, a virus of an identical subtype of HIV, which is carried by an infected person, is recombined into a defective virus, most parts of an env region are deleted, an intron with three groups of four +1 section double-chain miRNA (micro ribonucleic acid) is inserted, and the defective virus is completely identical to an HIV gene sequence expect env, can be replicated by self, and can be a defective virus with infection through anenv protein generated by HIV. When the defective virus is subjected to reverse transcription into a cell genome, becomes a previrus and is subjected to transcription to generate a sub-virus, former mRNA (messenger ribonucleic acid) generating env is sheared to remove the intron, then a great deal of double-chain miRNA can be generated, RNAi (ribonucleic acid interfere) can be generated, HIV sub-viruses, mRNA of env and new invading viruses can be killed, and thus an effect of treating Aids can be achieved.

Description

technical field [0001] The invention relates to the field of clinical medicine, in particular to a recombinant HIV deficient virus and a preparation method thereof. Background technique [0002] Since 1981 when the US CDC first reported the HIV virus, AIDS has spread at an alarming rate in the past 38 years and has become a serious global public health problem. According to the World Health Organization, there are currently about 36.7 million HIV-infected people in the world, with about 2 million new infections every year and more than 35 million deaths. According to a joint assessment by the Chinese Center for Disease Control and Prevention, UNAIDS, and the World Health Organization, by the end of 2018, there were estimated to be about 1.25 million surviving HIV-infected people in China. As of the end of September 2018, 850,000 surviving infections and 262,000 deaths were reported across the country. It is estimated that there are about 80,000 new infections every year. ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12N7/01C12N15/63A61K48/00A61K31/713A61P31/18
CPCC12N7/00C07K14/005C12N15/63A61K31/713A61P31/18C12N2740/16021C12N2740/16022
Inventor 戚其平张晓光戚本昊戚坤
Owner 北京君禾药业有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products